Premium
Even ‘low‐dose’ cabazitaxel requires careful and meticulous patient selection
Author(s) -
Heidenreich Axel,
Pfister David
Publication year - 2018
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.13879
Subject(s) - cabazitaxel , medicine , docetaxel , febrile neutropenia , neutropenia , prostate cancer , geriatric oncology , abiraterone acetate , cancer , intensive care medicine , oncology , chemotherapy , androgen deprivation therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom